首页|达格列净片联合吡格列酮片治疗2型糖尿病对糖脂代谢及血糖水平的影响

达格列净片联合吡格列酮片治疗2型糖尿病对糖脂代谢及血糖水平的影响

Effect of Dapagliflozin Tablet Combined with Pioglitazone Tablet on Glu-cose and Lipid Metabolism and Blood Glucose Level in the Treatment of Type 2 Diabetes Mellitus

扫码查看
目的 探究达格列净片与吡格列酮片联合治疗对2型糖尿病患者血糖水平的影响,并分析该联合疗法对糖脂代谢水平及不良反应发生情况的影响.方法 选取2021年1月—2023年9月盱眙县第二人民医院收治的82例2型糖尿病患者作为研究对象,根据随机数表法分为对照组和研究组,各41例.对照组采用吡格列酮片治疗,研究组采用达格列净片联合吡格列酮片治疗.对比两组血糖水平、血脂水平及不良反应发生情况.结果 治疗后,研究组空腹血糖、餐后2 h血糖、糖化血红蛋白水平低于对照组,差异有统计学意义(P均<0.05).研究组三酰甘油、总胆固醇、低密度脂蛋白胆固醇水平低于对照组,高密度脂蛋白胆固醇水平高于对照组,差异有统计学意义(P均<0.05).两组不良反应总发生率比较(12.20%vs 9.76%),差异无统计学意义(χ2=0.125,P>0.05).结论 临床治疗2型糖尿病患者时选用达格列净片与吡格列酮片联合治疗可有效控制血糖水平,改善血脂水平,具有较高的用药安全性.
Objective To investigate the effect of combination of dapagliflozin tablet and pioglitazone tablet on blood glucose level in patients with type 2 diabetes mellitus,and to analyze the effects of the combination therapy on the level of glucose and lipid metabolism and the occurrence of adverse reactions.Methods A total of 82 patients with type 2 diabetes mellitus from Xuyi County Second People's Hospital from January 2021 to September 2023 were se-lected as the study objects,and divided into control group and study group according to random number table method,with 41 patients in each group.The control group was treated with pioglitazone tablets,and the study group was treated with dapagliflozin tablets combined with pioglitazone tablets.The blood glucose level,blood lipid level and the incidence of adverse reactions were compared between the two groups.Results After treatment,the levels of fasting plasma glucose,2-hour postprandial plasma glucose,and hemoglobin A1c in the study group were lower than those in the control group,and the differences were statistically significant(all P<0.05).Compared with the control group,the levels of triglyceride,total cholesterol,and low density lipoprotein cholesterol were lower,and level of high density li-poprotein cholesterol was higher in the study group,and the differences were statistically significant(all P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(12.20%vs 9.76%)(χ2=0.125,P>0.05).Conclusion In the clinical treatment of type 2 diabetes patients,the combina-tion of dapagliflozin tablets and pioglitazone tablets can effectively control the level of blood glucose and improve the level of blood lipids,and has a high drug safety.

Dapagliflozin tabletPioglitazone tabletsType 2 diabetes mellitusGlycolipid metabolismBlood glu-coseAdverse reaction

高德虹、赵磊、娄朋

展开 >

盱眙县第二人民医院药剂科,江苏盱眙 211751

盱眙县第二人民医院内科,江苏盱眙 211751

达格列净片 吡格列酮片 2型糖尿病 糖脂代谢 血糖 不良反应

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(6)
  • 15